It is the first to demonstrate that the combination of FA with MLT might alleviate ERS by activating AMPK, then down-regulating PPARγ and reducing the expression of Plin2 and Plin5, subsequently promoting LD lipolysis, decreasing LD accumulation, and ultimately achieving effective prevention of hepatic steatosis. This evidence concerns the gene PLIN2 and fatty liver disease.